Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/4/2026

1. PLTR
2. SNAP
3. SKHY
4. SPY
5. INSP
6. JAZZ
7. ON
8. THRY
9. TKO
10. VERX

Go back to Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer
StemCells, Inc. (NASDAQ: TEM) Delayed: 47.62 +1.57 (3.41%)
Previous Close $46.05    52 Week High $0.45 
Open $46.75    52 Week Low $0.37 
Day High $47.68    P/E N/A 
Day Low $45.27    EPS $-0.31 
Volume 2,824,486